Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agentsIbrahim Aldoss, Vinod Pullarkat, Sanjeet Dadwal et al.|Blood Advances|2019Cited by 84
MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adultsCorinna La Rosa, Don J. Diamond, Jeff Longmate et al.|Blood|2016Cited by 81
Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant RecipientsIbrahim Aldoss, Corinna La Rosa, Lindsey R. Baden et al.|Annals of Internal Medicine|2020Cited by 74
Enhancer retargeting of <i>CDX2</i> and <i>UBTF::ATXN7L3</i> define a subtype of high-risk B-progenitor acute lymphoblastic leukemiaShunsuke Kimura, Charles G. Mullighan, Georgina L. Ryland et al.|Blood|2022Cited by 50
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous LeukemiaKaramjeet Sandhu, Vinod Pullarkat, Sanjeet Dadwal et al.|Biology of Blood and Marrow Transplantation|2020Cited by 43